| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT07477704 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult… |
Recruitment opened |
| 2026-06-11 | NCT07477704 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult… |
Trial sites expanded: 0 -> 6 locations |
| 2026-06-11 | NCT07477704 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult… |
date change Primary completion pushed: 2026-10-20 -> 2026-12-29 |
| 2026-06-03 | NCT07581808 Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07615166 Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in… | Active, Not Recruiting | |
| 2026-05-29 | NCT07615179 Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD) | Active, Not Recruiting | |
| 2026-05-14 | NCT07586540 Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05292404 | Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction | Acute Myocardial Infarction | Recruiting |
| NCT07581808 | Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention | Hypercholesterolemia | Recruiting |
| Phase 3 | |||
| NCT07586540 | Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque | Carotid Stenosis | Not Yet Recruiting |
| Phase 2 | |||
| NCT07477704 | A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult… | Hypercholesterolemia | Recruiting |
| Phase 1 | |||
| NCT04781322 | Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers | Alcohol Associated Liver Disease | Recruiting |
| Not specified | |||
| NCT05430828 | Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in… | Hypercholesterolemia | Recruiting |
| NCT07375225 | Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in… | Hypercholesterolaemia | Recruiting |
| NCT07615166 | Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in… | Atherosclerotic Cardiovascular Disease | Active, Not Recruiting |
| NCT07615179 | Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD) | Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events | Active, Not Recruiting |